Cytek Biosciences (CTKB)HHS awarded $498K
HHS awarded Cytek Biosciences a contract with $498K committed so far.
- $498K
- committed so far
- Signed
- Jul 22, 2026
- Updated
- Aug 31, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 17, 2025Federal contract · $55K obligatedDepartment of Veterans Affairs awarded Cytek Biosciences, Inc.: $55K obligated to date
- Feb 13, 2026Federal contract · $38K obligatedDepartment of Health and Human Services awarded Cytek Biosciences, Inc.: $38K obligated to date
- May 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 27, 2026, Philippe Busque, Ph.D. submitted his resignation from his position as the Senior Vice President, Global Sales and Services of Cytek Biosciences, Inc. (the “Company”), effective as of June 5, 2026, to pursue another career opportunity.”
- Jun 16, 2026Federal contract · $42K obligatedDepartment of Health and Human Services awarded Cytek Biosciences, Inc.: $42K obligated to date
- Jun 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 18, 2026, Valerie Barnett and Cytek Biosciences, Inc. (the “Company”) agreed that Ms. Barnett’s position as Chief Legal Officer and Corporate Secretary of the Company would terminate effective as of June 29, 2026.”
- Jul 9, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 9, 2026 (the “Separation Date”), the Company and Ms. Barnett entered into a severance agreement and release of all claims (the “Severance Agreement”) pursuant to which Ms. Barnett provided the Company with a release and waiver of claims.”
- Jul 22, 2026 · this disclosureFederal contract · $498K obligatedDepartment of Health and Human Services awarded Cytek Biosciences, Inc.: $498K obligated to date
What came next
- Jul 28, 2026Federal contract · $200K obligatedDepartment of Health and Human Services awarded Cytek Biosciences, Inc.: $200K obligated to date
- Jul 30, 2026Federal contract · $532K obligatedDepartment of Veterans Affairs awarded Cytek Biosciences, Inc.: $532K obligated to date
- Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 5, 2026Federal contract · $39K obligatedDepartment of Health and Human Services awarded Cytek Biosciences, Inc.: $39K obligated to date
- Sep 1, 2026Federal contract · $40K obligatedDepartment of Health and Human Services awarded Cytek Biosciences, Inc.: $40K obligated to date
- Sep 10, 2026Federal contract · $39K obligatedDepartment of Health and Human Services awarded Cytek Biosciences, Inc.: $39K obligated to date
- Sep 23, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
How to read USAspending.gov award record
The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.
Full guide: Contract ceiling vs obligated amount: the difference
What else is on file for Cytek Biosciences
For Cytek Biosciences, OQRO holds 8 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CTKB page.
How this filing works
Other disclosures at Cytek Biosciences
- USAspending.gov award recordSep 14, 2026
- USAspending.gov award recordSep 10, 2026
- USAspending.gov award recordAug 12, 2026
- USAspending.gov award recordAug 11, 2026
- USAspending.gov award recordAug 5, 2026
- USAspending.gov award recordAug 4, 2026
Everything OQRO holds on this company is on its CTKB page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data